Azitra (AZTR) Total Non-Current Liabilities (2022 - 2025)

Azitra (AZTR) posted Total Non-Current Liabilities of $1.2 million for Q4 2025, down 39.43% on a QoQ basis from $2.0 million in Q3 2025, and down 26.26% year-over-year from $1.7 million in Q4 2024.

Azitra (AZTR) Total Non-Current Liabilities (2022 - 2025) Analysis & Trends

Azitra's Total Non-Current Liabilities history runs 4 years deep, the most recent figure standing at $1.2 million for Q4 2025.

  • Quarterly Total Non-Current Liabilities fell 26.26% year-over-year to $1.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.2 million (down 26.26% YoY) and the FY2025 annual result came in at $1.2 million, down 26.26% from the prior year.
  • Total Non-Current Liabilities was $1.2 million for Q4 2025 at Azitra, down from $2.0 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $9.7 million in Q4 2022 and bottomed at $1.2 million in Q4 2025.
  • A 4-year average of $2.5 million and a median of $1.9 million in 2024 frame the typical range for Total Non-Current Liabilities.
  • Annual changes were most pronounced in 2023 — Total Non-Current Liabilities sank 77.58% — and 2025, when it increased 17.59%.
  • Azitra's Total Non-Current Liabilities stood at $9.7 million in 2022, then sank by 77.58% to $2.2 million in 2023, then declined by 23.39% to $1.7 million in 2024, then retreated by 26.26% to $1.2 million in 2025.
  • Business Quant data shows AZTR's Total Non-Current Liabilities at $1.2 million in Q4 2025, $2.0 million in Q3 2025, and $1.7 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Nanobiotix 1,769.80 Bn 1,769.74 Bn - 107.80 Mn
2 Akari Therapeutics 1,009.43 Bn 1,009.43 Bn - 19.49 Mn
3 BeOne Medicines 473.64 Bn 468.85 Bn 1.35 Bn 1.98 Bn
4 Vertex Pharmaceuticals 123.74 Bn 116.49 Bn 2.59 Bn 5.87 Bn
5 Regeneron Pharmaceuticals 71.73 Bn 62.97 Bn 3.31 Bn 7.32 Bn
6 Belite Bio 62.10 Bn 62.10 Bn - -
7 Argenx Se 54.68 Bn 49.49 Bn 1.41 Bn 40.00 Mn
8 Alnylam Pharmaceuticals 38.13 Bn 35.12 Bn 959.66 Mn 4.05 Bn
9 Revolution Medicines 36.21 Bn 36.21 Bn - 746.94 Mn
10 Azitra 2.03 Mn 2.03 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 1.22 Mn
Sep 30, 2025 2.02 Mn
Jun 30, 2025 1.73 Mn
Mar 31, 2025 1.50 Mn
Dec 31, 2024 1.66 Mn
Sep 30, 2024 1.72 Mn
Jun 30, 2024 2.15 Mn
Mar 31, 2024 1.74 Mn
Dec 31, 2023 2.17 Mn
Sep 30, 2023 2.10 Mn
Jun 30, 2023 2.43 Mn
Dec 31, 2022 9.66 Mn